Single-Arm Study to Assess the Efficacy of UVADEX® (Methoxsalen) Sterile Solution in Conjunction With the THERAKOS® CELLEX® Photopheresis System in Pediatric Patients With Steroid-Refractory Acute Graft-vs-Host Disease (aGvHD)
Phase of Trial: Phase III
Latest Information Update: 21 Oct 2017
At a glance
- Drugs Methoxsalen (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Sponsors Mallinckrodt Inc.; Therakos
- 22 Sep 2017 Planned End Date changed from 1 Nov 2018 to 1 Oct 2018.
- 12 May 2016 Planned End Date changed from 1 May 2017 to 1 Nov 2018.
- 12 May 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Oct 2018.